JTCS Speed Up Your Browser
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by del Nido, P. J.
Right arrow Articles by Tait, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by del Nido, P. J.
Right arrow Articles by Tait, G. A.

The Journal of Thoracic and Cardiovascular Surgery, Vol 89, 689-699, Copyright © 1985 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

The role of cardioplegic solution buffering in myocardial protection. A biochemical and histopathological assessment

PJ del Nido, GJ Wilson, DA Mickle, BG Bush, IM Rebeyka, P Klement, R Harding and GA Tait

The advantages of buffering cardioplegic solutions to improve adenosine triphosphate preservation and postarrest hemodynamic function have been previously promoted. We evaluated the benefit of histidine buffering (195 mmol/L) in a low sodium (27 mEq/L) cardioplegic solution (Roe's) in a canine model of multidose cardioplegic arrest. Four solutions, two unbuffered (K+ = 10 mEq/L and K+ = 30 mEq/L) and two buffered (K+ = 10 mEq/L and K+ = 30 mEq/L), were tested in four groups of dogs for a 4 1/2 hour arrest period followed by 1 hour of reperfusion. Use of the unbuffered solution resulted in a drop in myocardial adenosine triphosphate from 29 +/- 1 mmol/kg (mean +/- standard error of the mean) (K+ = 30 mEq/L) and 28 +/- 2 mmol/kg (K+ = 10 mEq/L) to 8 +/- 2 mmol/kg and 7 +/- 2 mmol/kg, respectively, during the arrest period. In both buffered groups, adenosine triphosphate remained at preischemic levels during the entire arrest period. Myocardial glycogen followed the same pattern as adenosine triphosphate in the buffered groups. Lactate production was markedly elevated in all groups during ischemia. Postarrest hemodynamic function, as assessed by intraventricular isovolumic developed pressure measurements, was better (p less than 0.05) in the buffered low-potassium group than in the other three groups. The extent of myocardial necrosis, measured by triphenyl tetrazolium staining and confirmed by electron microscopy, was minimal (2% +/- 1% of biventricular mass) in the buffered low-potassium group, significantly greater (7% +/- 2% and 10% +/- 2%) in the unbuffered high- potassium and low-potassium groups, respectively, and highest (35% +/- 9%) in the buffered high-potassium group. These findings indicate that significant buffering capacity (similar to that of blood) in a crystalloid cardioplegic solution can be effective in preserving myocardial adenosine triphosphate stores, improving postarrest contractile function, and minimizing myocardial necrosis, provided the combination of high extracellular potassium and high pH levels is avoided.


This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. K. Najm, W. J. Wallen, M. P. Belanger, W. G. Williams, J. G. Coles, G. S. Van Arsdell, M. D. Black, C. Boutin, and C. Wittnich
DOES THE DEGREE OF CYANOSIS AFFECT MYOCARDIAL ADENOSINE TRIPHOSPHATE LEVELS AND FUNCTION IN CHILDREN UNDERGOING SURGICAL PROCEDURES FOR CONGENITAL HEART DISEASE?
J. Thorac. Cardiovasc. Surg., March 1, 2000; 119(3): 515 - 524.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Takeuchi, H. Cao-Danh, A. Kawai, A. Ohkado, H. Konishi, F. X. McGowan, and P. J. del Nido
Prolonged preservation of the blood-perfused canine heart with glycolysis-promoting solution
Ann. Thorac. Surg., September 1, 1999; 68(3): 903 - 907.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Hachida, M. Nonoyama, Y. Bonkohara, N. Hanayama, S. Saitou, T. Maeda, A. Ohkado, H. Lu, and H. Koyanagi
Clinical Assessment of Prolonged Myocardial Preservation for Patients With a Severely Dilated Heart
Ann. Thorac. Surg., July 1, 1997; 64(1): 59 - 63.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. Ohkado, H. Cao-Danh, K. E. Sommers, and P. J. del Nido
Evaluation of highly buffered low-calcium solution for long-term preservation of the heartComparison with University of Wisconsin solution
J. Thorac. Cardiovasc. Surg., October 1, 1994; 108(4): 762 - 771.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
F. X. McGowan Jr., H. Cao-Danh, K. Takeuchi, P. J. Davis, and P. J. del Nido
Prolonged neonatal myocardial preservation with a highly buffered low-calcium solution
J. Thorac. Cardiovasc. Surg., October 1, 1994; 108(4): 772 - 779.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1985 by The American Association for Thoracic Surgery.